Turn Therapeutics Inc. Common Stock (TTRX) — Working Capital to Net Assets Ratio
Turn Therapeutics Inc. Common Stock (TTRX) has a Working Capital to Net Assets ratio of 242.3% as of June 2026. Working capital of $1.66 Million (current assets of $10.43 Million minus current liabilities of $8.76 Million) is measured against net assets of $686.89K. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Turn Therapeutics Inc. Common Stock Working Capital to Net Assets (2023–2025)
This chart shows how Turn Therapeutics Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 242.3%, reflecting working capital of $1.66 Million against net assets of $686.89K USD. For the complete balance sheet picture, see how large is Turn Therapeutics Inc. Common Stock's balance sheet.
Annual Working Capital to Net Assets for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Turn Therapeutics Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read TTRX current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -17.2% | $-806.98K | $4.69 Million | $5.20 Million | $6.00 Million | ▲ +202.6 pp |
| 2024 | -219.8% | $389.99K | $-177.43K | $1.10 Million | $707.93K | ▼ -1050.0 pp |
| 2023 | 830.2% | $712.04K | $85.77K | $1.20 Million | $489.78K | — |